Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.

Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P.

BMC Cancer. 2018 Jan 10;18(1):68. doi: 10.1186/s12885-017-3948-3.

2.

NudE regulates dynein at kinetochores but is dispensable for other dynein functions in the C. elegans early embryo.

Simões PA, Celestino R, Carvalho AX, Gassmann R.

J Cell Sci. 2018 Jan 8;131(1). pii: jcs212159. doi: 10.1242/jcs.212159.

3.

Molecular mechanism of dynein recruitment to kinetochores by the Rod-Zw10-Zwilch complex and Spindly.

Gama JB, Pereira C, Simões PA, Celestino R, Reis RM, Barbosa DJ, Pires HR, Carvalho C, Amorim J, Carvalho AX, Cheerambathur DK, Gassmann R.

J Cell Biol. 2017 Apr 3;216(4):943-960. doi: 10.1083/jcb.201610108. Epub 2017 Mar 20.

4.

Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.

Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M.

Am J Surg Pathol. 2017 Jun;41(6):854-860. doi: 10.1097/PAS.0000000000000793.

PMID:
28009606
5.

Reassessing the Evolutionary History of the 17q21 Inversion Polymorphism.

Alves JM, Lima AC, Pais IA, Amir N, Celestino R, Piras G, Monne M, Comas D, Heutink P, Chikhi L, Amorim A, Lopes AM.

Genome Biol Evol. 2015 Nov 11;7(12):3239-48. doi: 10.1093/gbe/evv214.

6.

Molecular and chemical characterization of vetiver, Chrysopogon zizanioides (L.) Roberty, germplasm.

Celestino RS, Zucchi MI, Pinheiro JB, Campos JB, Pereira AA, Bianchini FG, Lima RN, Arrigoni-Blank MF, Alves PB, Blank AF.

Genet Mol Res. 2015 Aug 14;14(3):9452-68. doi: 10.4238/2015.August.14.9.

7.

[Perception of newly graduated physicians on clinical skills acquired in medical schools in Lima, Perú].

Taype-Rondán Á, Inga-Berrospi F, Celestino RC, Bastidas F.

Rev Med Chil. 2015 Apr;143(4):540-2. doi: 10.4067/S0034-98872015000400019. Spanish. No abstract available.

8.

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.

Camilo V, Barros R, Celestino R, Castro P, Vieira J, Teixeira MR, Carneiro F, Pinto-de-Sousa J, David L, Almeida R.

BMC Cancer. 2014 Oct 9;14:753. doi: 10.1186/1471-2407-14-753.

9.

Primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology?

Bolfi F, Domingues MA, Sobrinho-Simões M, Soares P, Celestino R, Castilho EC, Carelli G, Paes NS, Mazeto GM.

Case Rep Pathol. 2014;2014:301780. doi: 10.1155/2014/301780. Epub 2014 Sep 9.

10.

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).

Campanella NC, Celestino R, Pestana A, Scapulatempo-Neto C, de Oliveira AT, Brito MJ, Gouveia A, Lopes JM, Guimarães DP, Soares P, Reis RM.

Eur J Hum Genet. 2015 Jun;23(6):877-9. doi: 10.1038/ejhg.2014.195. Epub 2014 Sep 24.

11.

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Vinagre J, Pinto V, Celestino R, Reis M, Pópulo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Máximo V, Sobrinho-Simões M, Soares P.

Virchows Arch. 2014 Aug;465(2):119-33. doi: 10.1007/s00428-014-1608-4. Epub 2014 Jul 22. Review.

PMID:
25048572
12.

Prognostic biomarkers in thyroid cancer.

Soares P, Celestino R, Melo M, Fonseca E, Sobrinho-Simões M.

Virchows Arch. 2014 Mar;464(3):333-46. doi: 10.1007/s00428-013-1521-2. Epub 2014 Feb 1. Review.

PMID:
24487783
13.

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29.

14.

Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?

Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simões M.

Int J Surg Pathol. 2014 Apr;22(2):113-9. doi: 10.1177/1066896913517394. Epub 2014 Jan 7. Review.

PMID:
24401191
15.

Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.

Boaventura P, Pereira D, Celestino R, Mendes A, Nakasawa T, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2013 Oct 3;169(5):673-9. doi: 10.1530/EJE-13-0543. Print 2013 Nov.

16.

Frequency of TERT promoter mutations in human cancers.

Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P.

Nat Commun. 2013;4:2185. doi: 10.1038/ncomms3185.

PMID:
23887589
17.

Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.

Nakazawa T, Celestino R, Machado JC, Cameselle-Teijeiro JM, Vinagre J, Eloy C, Benserai F, Lameche S, Soares P, Sobrinho-Simões M.

Int J Surg Pathol. 2013 Aug;21(4):379-89. doi: 10.1177/1066896912473355. Epub 2013 Jan 24.

PMID:
23349472
18.

Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes.

Celestino R, Sigstad E, Løvf M, Thomassen GO, Grøholt KK, Jørgensen LH, Berner A, Castro P, Lothe RA, Bjøro T, Sobrinho-Simões M, Soares P, Skotheim RI.

Genes Chromosomes Cancer. 2012 Dec;51(12):1154-64. doi: 10.1002/gcc.22003. Epub 2012 Sep 7.

PMID:
22961909
19.

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.

Celestino R, Lima J, Faustino A, Vinagre J, Máximo V, Gouveia A, Soares P, Lopes JM.

Eur J Hum Genet. 2013 May;21(5):503-10. doi: 10.1038/ejhg.2012.205. Epub 2012 Sep 5.

20.

RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.

de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P.

Histopathology. 2012 Nov;61(5):833-43. doi: 10.1111/j.1365-2559.2012.04276.x. Epub 2012 Jul 17. Review.

PMID:
22803838
21.

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M.

Curr Genomics. 2011 Dec;12(8):609-17. doi: 10.2174/138920211798120853.

22.

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.

Celestino R, Lima J, Faustino A, Máximo V, Gouveia A, Vinagre J, Soares P, Lopes JM.

Fam Cancer. 2012 Jun;11(2):189-94. doi: 10.1007/s10689-011-9499-x.

PMID:
22160509
23.

Fusion gene microarray reveals cancer type-specificity among fusion genes.

Løvf M, Thomassen GO, Bakken AC, Celestino R, Fioretos T, Lind GE, Lothe RA, Skotheim RI.

Genes Chromosomes Cancer. 2011 May;50(5):348-57. doi: 10.1002/gcc.20860. Epub 2011 Feb 8.

PMID:
21305644
24.

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.

Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J.

Endocr Relat Cancer. 2010 Jun 3;17(3):599-610. doi: 10.1677/ERC-09-0069. Print 2010 Sep.

25.

A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.

Celestino R, Magalhães J, Castro P, Triller M, Vinagre J, Soares P, Sobrinho-Simões M.

Histopathology. 2009 Oct;55(4):482-7. doi: 10.1111/j.1365-2559.2009.03401.x. No abstract available.

PMID:
19817905
26.

Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior.

Cameselle-Teijeiro J, Menasce LP, Yap BK, Colaco RJ, Castro P, Celestino R, Ruíz-Ponte C, Soares P, Sobrinho-Simões M.

Am J Clin Pathol. 2009 Jan;131(1):134-42. doi: 10.1309/AJCP7ULS0VSISBEB.

PMID:
19095577
27.

Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.

Cameselle-Teijeiro J, Pardal F, Eloy C, Ruiz-Ponte C, Celestino R, Castro P, Soares P, Sobrinho-Simões M.

Hum Pathol. 2008 Oct;39(10):1540-7. doi: 10.1016/j.humpath.2008.01.014. Epub 2008 Jul 7.

PMID:
18602667
28.

[Clinical statistical study of 238 cases of hepatic cirrhosis].

Meeroff M, Pelizzari ON, Celestino R, Feldfeber B, Pinchuk L, Folino A, Alicino A, Cestoni J, Bekier B, Goschinsky J, Aschkenazi S, Luis AM, Meeroff JC, Rudovsky M, Mayorga O, Gregorio JM, Mandelman J.

Prensa Med Argent. 1966 Jul 15;53(28):1553-60. Spanish. No abstract available.

PMID:
5989088
29.

[Comparative study of transaminases with other elements of the hepatogram, especially reactions of serocolloidal lability, in liver diseases].

Meeroff M, Folino AR, Pelizzari ON, Feldfeber B, Celestino R.

Rev Esp Enferm Apar Dig. 1966 Feb;25(2):165-87. Spanish. No abstract available.

PMID:
5907429
30.

[PERFORATION OF THE ESOPHAGUS BY COBALT PEARLS].

CELESTINO RR, CORTE FB, FALCON O, MEEROFF M.

Prensa Med Argent. 1964 Sep 18;51:739-41. Spanish. No abstract available.

PMID:
14229049
31.

[Clinical parasitological syndromes].

MEEROFF M, CELESTINO R.

Prensa Med Argent. 1961 Nov 24;48:376-87. Spanish. No abstract available.

PMID:
14472066
32.

[Parasitic clinical syndromes].

MEEROFF M, CELESTINO R.

Medicina (Mex). 1962 Nov 10;42:473-9 concl. Spanish. No abstract available.

PMID:
13934440
33.

[Clinical parasitological syndromes].

MEEROFF M, CELESTINO R.

Medicina (Mex). 1962 Oct 25;42:450-7 contd. Spanish. No abstract available.

PMID:
13934441
34.

[Retroperitoneal fibrosis].

ROCCHI A, MEEROFF M, CELESTINO R.

Prensa Med Argent. 1961 Oct 20;48:2879-84. Spanish. No abstract available.

PMID:
14492977
35.

[Leiomyoma of the colon].

CELESTINO RR, CIRUZZI A, REBERENDO S, FELDFEBER B, MEEROFF M.

Prensa Med Argent. 1961 Mar 10;48:630-4. Spanish. No abstract available.

PMID:
13691871
36.

[Leiomyoma of the colon].

CELESTINO RR, CIRUZZI A, REBERENDO S, FELDFEBER B, MEEROFF M.

Rev Esp Enferm Apar Dig Nutr. 1960 Dec;19:1315-25. Spanish. No abstract available.

PMID:
13691872
37.

[New amebicides].

MEEROFF M, CELESTINO RR.

Prensa Med Argent. 1960 Apr 22;47:1029-33. Spanish. No abstract available.

PMID:
13768927
38.

[Thrombocytopenic purpura caused by mephrobamate].

MEEROFF M, BENITEZ L, CELESTINO R, QUIROGA E.

Dia Med. 1959 May 25;31(33):846 passim. Spanish. No abstract available.

PMID:
13672012
39.

[Gastroscopy in gastroduodenal ulcer].

RYBAK BJ, CELESTINO RR.

Sem Med. 1957 Nov 20;111(Suppl 19):648-9 passim. Spanish. No abstract available.

PMID:
13529123

Supplemental Content

Loading ...
Support Center